You are viewing the site in preview mode
Skip to main content
| |
EQ-5D-3L at 6 months (mean)
|
EQ-5D-3L at 12 months (mean)
|
Difference between 12 and 6 months EQ-5D-3L (95% CI)
|
Effect size (Cohen’s D)a
|
n
|
% reporting 3L score increase
|
|---|
|
3L-VAS
|
|
Improved
|
0.73
|
0.84
|
0.10 (− 0.02 to 0.24)
|
0.41
|
23
|
39
|
|
No change
|
0.92
|
0.71
|
− 0.20 (− 0.48 to 0.06)
|
− 0.67
|
12
|
25
|
|
Worsened
|
0.82
|
0.82
|
0.00 (− 0.08 to 0.09)
|
0.00
|
13
|
23
|
| |
EQ-5D-5L at 6 months (mean)
|
EQ-5D-5L at 12 months (mean)
|
Difference between 12 and 6 months EQ-5D-5L (95% CI)
|
Effect size (Cohen’s D)
|
n
|
% reporting 5L score increase
|
|---|
|
5L-VAS
|
|
Improved
|
0.76
|
0.83
|
0.06 (0.00 to 0.14)
|
0.30
|
23
|
48
|
|
No change
|
0.91
|
0.72
|
− 0.19 (− 0.47 to 0.09)
|
− 0.61
|
12
|
33
|
|
Worsened
|
0.84
|
0.81
|
− 0.02 (− 0.07 to 0.01)
|
− 0.18
|
13
|
23
|
- aCohen’s D effect sizes of between 0.2 and 0.5 are considered small, 0.5 and 0.8 moderate and > 0.8 large
